REGN — Regeneron Pharmaceuticals, Inc. stock price, charts and financials

QT59Regeneron Pharmaceuticals, Inc.

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
808.05
+23.69+3.02%
OverviewShort InterestFilings
REGNQT59Regeneron Pharmaceuticals, Inc.·NASDAQ
808.05+3.02%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Aug 07, 202613F-HRInstitutional investment manager holdings report
Jul 30, 20268-KCurrent report
Jul 30, 202610-QQuarterly report
Jul 07, 20264Statement of changes in beneficial ownership
Jul 06, 20268-KCurrent report
Jun 17, 20268-KCurrent report
May 08, 202613F-HRInstitutional investment manager holdings report
May 04, 20264Statement of changes in beneficial ownership
Apr 30, 2026SC 13GBeneficial ownership statement (passive)
Apr 29, 202610-QQuarterly report
Apr 29, 20268-KCurrent report
Apr 24, 2026DEF 14ADefinitive proxy statement
Apr 24, 2026DEFA14AAdditional proxy soliciting materials
Apr 24, 2026ARSAnnual report to shareholders
Apr 08, 20268-KCurrent report
Apr 03, 20264Statement of changes in beneficial ownership
Mar 27, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Mar 03, 20264Statement of changes in beneficial ownership
Feb 23, 20264Statement of changes in beneficial ownership
Feb 19, 2026144Notice of proposed sale of restricted securities
Feb 11, 20264Statement of changes in beneficial ownership
Feb 11, 20264Statement of changes in beneficial ownership
Feb 09, 2026144Notice of proposed sale of restricted securities
Feb 09, 2026144Notice of proposed sale of restricted securities
Feb 06, 202613F-HRInstitutional investment manager holdings report
#1 / 25 of 506
Page
▼
/ 21